-
Novo Nordisk Skyrockets To $506B Valuation Driven By 'Miracle' Drugs Ozempic, Wegovy
Wednesday, January 31, 2024 - 7:57am | 631Novo Nordisk (NYSE:NVO) has reported a remarkable increase in its market value, reaching $500 billion, driven by a surge in demand for its key drugs. What Happened: The Danish pharmaceutical company’s market value soared to $506 billion on Wednesday following the release of its 2023 earnings...
-
Ozempic Users Might Experience Caloric Intake Rise Post-Discontinuation: Survey
Monday, January 8, 2024 - 11:14pm | 570Deutsche Bank has recently conducted a survey suggesting that patients using Novo Nordisk A/S (NYSE:NVO) weight loss medication, Ozempic, may increase their caloric intake after discontinuing the treatment. What Happened: The survey involved 600 U.S. consumers. Seventy percent of the participants ...
-
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
Monday, December 4, 2023 - 9:24pm | 645What Happened: Jim Cramer outlined fresh investment prospects on Monday, revolving around the growing demand for GLP-1 drugs, typically administered for diabetes and obesity treatment. As reported by CNBC, investors initially expressed concerns about these drugs’ market impact. However, with...
-
Novo Nordisk Ups Outlook Amid Surging Demand For Weight Loss Drug Wegovy, Ozempic
Saturday, October 14, 2023 - 12:23am | 311Following a surge in demand for its weight-loss drug Wegovy and diabetes medication Ozempic, Danish pharmaceutical company Novo Nordisk (NYSE:NVO) has revised its full-year sales and operating profit outlook. Novo Nordisk is now forecasting a sales growth for 2023 in local currencies of 32% to 38...
-
Tempest Therapeutics, Microsoft, Birkenstock, Novo Nordisk, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Wednesday, October 11, 2023 - 10:16pm | 660Major U.S. stock indices ended in the green on Wednesday, with the Nasdaq Composite marking notable gains of nearly 100 points. The Dow also ended Wednesday’s session in the green, while the S&P 500 experienced a slight uptick. The Nasdaq ended the day 96.83 points higher at 13,659.68,...
-
Wegovy Maker Novo Nordisk, Akero Therapeutics, Eli Lilly, Athena Consumer Acquisition, Tesla: Why These 5 Stocks Are Trending Today
Tuesday, October 10, 2023 - 9:56pm | 625U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 130 points on Tuesday. The Dow traded up 0.4% to 33,739.30 while the NASDAQ rose 0.58% to 13,562.84. The S&P 500 also rose, gaining 0.52% to 4,358.24. These are the top stocks that gained the attention of...
-
Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them
Monday, October 9, 2023 - 5:43am | 544New side effects of the ‘miracle’ weight loss drug Ozempic are emerging, causing concern among patients and healthcare professionals alike. As reported by Salon, Ozempic, commonly used for weight loss and diabetes management, is coming under scrutiny for potential long-...
-
Snacks In The Ozempic Era: Food, Beverage Stocks Crash With Weight Loss Drugs On The Rise
Friday, October 6, 2023 - 4:01pm | 1471Stocks in the food and beverage industry experienced their most challenging week since May 2022, further extending the declines seen in the preceding weeks. The First Trust Nasdaq Food & Beverage ETF (NYSE:FTXG) plummeted by over 5% this week, marking its third consecutive week of losses and...
-
Novo Nordisk Eyes Social Inequality To Enhance Access To Wegovy: 'Have To Be More Intentional'
Friday, August 25, 2023 - 7:24am | 389The CEO of Novo Nordisk (NYSE:NVO), Lars Fruergaard Jorgensen, announced on Friday that the company plans to collaborate with European healthcare systems. The aim is to improve access to its weight-loss drug, Wegovy, for less fortunate and more obese individuals, according to Reuters. “...
-
Darcey Silva Accused Of Using 'Miracle' Drug Ozempic After Showing Dramatic Weight Loss
Friday, August 25, 2023 - 5:52am | 368Reality TV star, Darcey Silva, is facing accusations of using the ‘miracle’ weight loss drug Ozempic, following her recent post showcasing her significantly slimmer figure, Monsters and Critics reported. Silva and her twin, stars of “Darcey & Stacey,” are currently...
-
These Three New Markets May Propel Novo Nordisk's Ozempic To Greater Heights
Friday, August 25, 2023 - 3:08am | 507Novo Nordisk’s (NYSE:NVO) popular semaglutide drugs, Wegovy and Ozempic, may unlock three potential new markets, potentially boosting the company’s fortunes, The Motley Fool reported. Over the past year, Novo Nordisk‘s shares have surged 79%, largely due to the success of its...
-
Ozempic Competitor Wegovy Could Prevent 1.5M Heart Attacks And Strokes Over 10 Years, Study Reveals
Wednesday, August 16, 2023 - 11:33pm | 348Novo Nordisk’s weight loss injection, Wegovy, could potentially thwart 1.5 million heart attacks and strokes over 10 years, according to a recent study, reports CNBC. Researchers from the University of California, Irvine discovered that Wegovy could also result in 43...
-
Tracy Morgan Credits 'Miracle' Weight Loss Drug Ozempic For Shedding Pounds: 'I Ain't Letting It Go!'
Tuesday, August 15, 2023 - 3:50am | 395Comedian Tracy Morgan reveals his weight loss secret is the ‘miracle’ drug Ozempic. As per E! Online, the 54-year-old confessed during an appearance on “Today with Hoda & Jenna”, that the Type-2 diabetes medication has been instrumental in his weight loss...
-
Weight-Loss Drugs Ozempic, Wegovy Pose Life-Threatening Risks For Surgery And Anesthesia Patients: Expert Warns
Sunday, August 13, 2023 - 11:57pm | 411Weight-loss medications Wegovy and Ozempic may cause life-threatening complications in patients needing surgical procedures, reports Fortune Well. Patients using these drugs may face fatal consequences during surgery or other procedures requiring anesthesia. This is due to the drugs’...
-
Obesity Drug Wegovy Sales Jump 365% In H1 As Novo Nordisk Reports Solid Results, Raises FY23 Guidance
Thursday, August 10, 2023 - 3:49am | 458Danish pharma giant Novo Nordisk A/S (NYSE:NVO) reported a strong increase in first-half sales and profits and also hiked its guidance for the full year for the second time this year. What Happened: Novo Nordisk said its net sales for the first half of the year climbed 29% year-over-year to 107.67...